This page shows the latest amphetamine and dextroamphetamine news and features for those working in and with pharma, biotech and healthcare.
attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and dextroamphetamine). ... as well as Intuniv (guanfacine) - another ADHD drug - and treatment for hereditary angioedema Firazyr (icatibant).
Net profit for Shire recovers from payment to Acceleron and impairment charges relating to the divestment of Daytrana. ... Products that performed particularly well in the quarter included ADHD treatments Vyvanse (lisdexamfetamine) and Adderall XR
Applicants' work experience, volunteer/extracurricular activities, and academic transcripts will also be taken into account. ... use as adjunctive therapy to stimulants; the extended-release drug Vyvanse (lisdexamfetamine dimesylate), which was approved
The FDA has approved Shire's ADHD drug Intuniv for the new indication of adjunctive therapy to stimulants in children and adolescents aged six to 17. ... The company's ADHD portfolio also includes the extended-release drug VyVanse (lisdexamfetamine
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...